Schizophrenia, bipolar disorder and major depression F20 F31 F33
Conditions
Interventions
Group 1: 1. Patients with schizophrenia: MR-Scan, Blood sample for genetyping, clinical evaluation, extended neuropsychological tests, questionaires to assess psychological variables as well as envi
Sponsors
Zentrales Institut für seelische Gesundheit, Abteilung Psychiatrie und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: - Ability to understand study protocol and give written informed consent
Exclusion criteria
Exclusion criteria: - MR exclusion criteria (metal implants, brain surgery, permanent makeup) - Current alcohol or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of multivariate neurocognitive markers, that allow the transdiagnostic classification of patient subgroups according to biological criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Find evidence for genetic contributions to disorder-specific and transdiagnostic neurocognitve markers. | — |
Countries
Germany
Contacts
Public ContactAndreas Meyer-Lindenberg
Zentrales Institut für seelische Gesundheit, Abteilung Psychiatrie und Psychotherapie
Outcome results
None listed